SEALSQ Corp (NASDAQ: LAES) ("SEALSQ" or "Company"), a company that focuses on developing and selling Semiconductors, PKI, and Post-Quantum technology hardware and software products, today announced ...

Hong Kong, Dec. 26, 2024 (GLOBE NEWSWIRE) -- SOLOWIN HOLDINGS (Nasdaq: SWIN) (“SOLOWIN” or the “Company”), a leading financial services firm providing high-net-worth and institutional investors with ...

The Board of Directors decided to appoint Mr. Tayfun Bayazıt, an independent member of the Board of Directors, as new member of the Corporate Governance Committee to replace Mr. Hikmet Ersek.

「金猿獎」作為大數據領域的標杆性獎項，其每年的獲獎技術和產品，不僅在技術上有著創新突破，更在實際應用中展現出了強大的生命力和實用價值。該獎項以其嚴格的評選標準、公正的評選流程以及高質量的獲獎技術和產品，贏得了業內外的廣泛認可和讚譽；彰顯了數據要素如何成為驅動營銷、打破行業壁壘的新引擎。

Comprehensive Presentation of Wi-Fi 7 and Wi-Fi HaLow Technologies. At the event, AsiaRF will highlight both Wi-Fi 7 and ...

“We recently reaffirmed that our cash resources were expected to fund our operations into the fourth quarter of 2026. With the incremental $30M gross proceeds from the sale of these pre-funded ...

Expands Its IoT Wireless Connect Portfolio With Cutting-Edge 5G Technology Strengthens Its Competitive Offering, Adds New Blue-Chip Customers IRVINE, Calif., (GLOBE NEWSWIRE) -- Lantronix Inc. (NASDAQ ...

TOKYO, Dec. 26, 2024 /PRNewswire/ -- Video may have killed the radio star, but the rise of the internet did not make videos ...

Recognized as the world's largest modular student residence (calculated by the number of bed spaces), the Residential Village was built in partnership with main contractor Gammon Construction Limited ...

Astute Analytica, a prominent market research firm, has recently published a comprehensive report that offers an extensive analysis of the North America Food Trucks Market. This report goes beyond ...

The report provides a comprehensive analysis of the potential of E-commerce Industry in Mexico. The report covers an overview and genesis of the industry, market size in terms of number of products ...

JSKN033-102 is an open-label, multicenter, Phase Ⅰ/Ⅱ clinical study designed to evaluate the safety, tolerability, pharmacokinetics/pharmacodynamics and anti-tumor activity of JSKN033 in patients with ...